Abstract
One major mutation, ΔF508, causing cystic fibrosis (CF) is found in most populations around the world. Among CF patients of Jewish Ashkenazi origin two major mutations, W1282X and AF508 were found. We compared the relative frequencies of the two major mutations found in this patient population to their relative frequencies in the healthy population. The studied patient population included the entire CF Jewish Ashkenazi patient population in Israel (238 chromosomes), and a small group of Jewish Ashkenazi patients in the USA (57 chromosomes). Among these, 79 (27%) chromosomes carried the ΔF508 mutation, and 151 (51%) the W1282X mutation. In addition, we have analyzed the results of screening 1,946 unrelated healthy Jewish Ashkenazi individuals for the ΔF508 and the W1282X mutations. Surprisingly, an almost equal number of carriers of the ΔF508 (35) and W1282X (36) was found. The difference between the relative proportions of the mutations in the two groups is statistically significant (p = 0.025). A striking manifestation of this difference is revealed in the analysis of patients’ genotypes. There were 36 patients homozygous for W1282X, while only 7 patients were homozygous for ΔF508, although the number of ΔF508 carriers in the general Jewish Ashkenazi population is almost equal to the number of W1282X carriers. This difference in allele frequencies found between healthy carriers and CF patients in the Jewish Ashkenazi population might not be unique to this ethnic group nor to the CF disease. The results indicate that the common practice of inferring general population epidemiologic parameters directly from patients information is liable to introduce biases. Thus, widespread screenings should be preceded by smaller-scale pilot studies designed to verify that the mutation frequencies in the patient population represent the carrier frequencies in the relevant general population.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Boat TF, Welsh MJ, Beaudet AL: The Metabolic Basis of Inherited Diseases. New York, McGraw-Hill, 1989.
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C: Identification of the cystic fibrosis gene: Genetic analysis. Science 1989;245:1073–1080
Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Seret H, Yaar L, Kerem E, Kerem B: Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 1992;50:222–228
Abeliovich D, Pashut Lavon I, Lerer I, Cohen T, Springer C, Avital A, Cutting GR: Screening for five mutations detects 97% of cystic fibrosis chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992;51:951–956
Rommens JM, Kerem B, Greer W, Chang P, Tsui L-C, Ray P: Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990;46:395–396
Walpole RE, Myers RH: Probability and Statistics for Engineers and Scientists. New York, MacMillan, 1978.
Zamostiano R, Noiman S, Yahav J, Szeinberg A, Kerem B, Gazit E: Screening for carriers of cystic fibrosis mutations in Ashkenazi volunteers. Harefuah 1993;124:202–205
Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, Marteau T: Uptake of cystic fibrosis testing in primary care: Supply push or demand pull? BMJ 1993,306:1584–1586.
Mennie M, Gilfillan A, Compton M, Curtis L, Liston WA, Pullen I, Whyte DA, Brock DJ: Prenatal screening for cystic fibrosis. Lancet 1992;340:214–216
Lee R, Nezmer L, Witt DR, Farmer G, Fitzgerald P, Fishbach A, Holzman J, Kornfeld S, Palmer R, Shay G: Identification of previously undiagnosed cystic fibrosis patients: An unexpected outcome of prenatal carrier screening. Am J Hum Genet 1992;51:A32.
Gregg R, Wilfond B, Laxova A, Hassemer D, Farrell P: Cystic fibrosis carrier frequency determined by newborn screening and by ΔF508 analysis of the general population. Pediatr Pulmonol Suppl 1991;6:238.
Kerem E, Corey M, Kerem B, Rommens JM, Markiewicz D, Levison H, Tsui L-C, Durie P: The relation between genotype and phenotype in cystic fibrosis — Analysis of the most common mutation ΔF508. New Engl J Med 1990;323:1517–1522
Santis G, Osborne L, Knight RA, Hodson ME: Linked marker haplotypes and the ΔF508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet 1990;35:1426–1429
Williams C, Davies D, Williamson R: Segregation of ΔF508 and normal CFTR alleles in human sperm. Hum Mol Genet 1993;2:445–448
Lyttle TW: Cheaters sometimes prosper: Distortion of mendelian segregation by meiotic drive. Trends Genet 1993;9:205–210
Agulnik SI, Sabantsev ID, Ruvinsky AO: Effect of sperm genotype on chromatid segregation in female mice heterozygous for aberrant chromosome 1. Genet Res 1993;61:97–100
Acknowledgements
We wish to thank Dr. Christine M. Eng and Robert J. Desnick from Mount Sinai Medical Center, New York, and Dr. Dvora Abeliovich from the Hadassah Medical Center, Jerusalem, for permission to cite their most updated results; Dr. Tamar Schapp, from the Hadassah Medical Center, for helpful discussions; and Dr. Haana Blau from the Beilinson Medical Center, Petach Tikva, Dr. Lea Ben Tur from the Rambam Medical Center, Haifa, Dr. Yossi Rivlin from the Carmel Medical Center, Haifa, Dr. Haim Springer from the Hadassah Medical Center, Dr. Asher Tal from the Soroka Medical Center, Beersheva, and Dr. Yaakov Yahav from the Shiba Medical Center, Tel Aviv for providing patient data.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalman, Y.M., Kerem, E., Darvasi, A. et al. Difference in Frequencies of the Cystic Fibrosis Alleles, ΔF508 and W1282X, between Carriers and Patients. Eur J Hum Genet 2, 77–82 (1994). https://doi.org/10.1159/000472347
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1159/000472347
Key Words
This article is cited by
-
Targeted Therapy for Cystic Fibrosis
Molecular Diagnosis & Therapy (2006)
-
Recent Advances in Reproductive Genetic Technologies
Nature Biotechnology (1995)
-
Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel
Human Genetics (1995)
